December 2024

CHENGDU, China, Dec. 21, 2024 /PRNewswire/ — Under the aegis of the China Federation of Literary and Art Circles (CFLAC), the Sichuan Provincial Federation of Literary and Art Circles and the Chengdu Federation of Literary and Art Circles hosted the New Literature & Art • New Perspectiv

FDA approval is based on data from the pivotal phase 3 trial (explorer7) establishing the safety and efficacy of Alhemo® for daily prevention of bleeds in adults and pediatric patients 12 years of age and older living with hemophilia A or B with inhibitors Results from the pivotal trial showed an 8